All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
ETF screener
03186
HK0001254553
Passive ETFEquity

03186 ETF · E Fund (HK) Solactive Biopharma Select Index ETF

The 03186 Exchange Traded Fund (ETF) is provided by E Fund Management. It is built to track an index: Solactive Biopharma Select Index. The 03186 ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. This share class generates a stream of income by distributing dividends.
Real-time data unavailable for 03186
LIVE
CLOSED
Last price
N/A
1M perf.
+6.97%
1M flows
N/A
AuM
€3.2M
TER
0.9%
Rating
Not rated
03186
N/A

Performance & flows

April 2, 2026 → July 2, 2026
0-20%-15%-10%-5%0%MAYJUNJULMAYJUNJUL
Create a free account to view the flows graph
03186
HK$14.35
-13.13%

Historic performance and flows

1M3M1Y3Y5YMTDQTD
YTD
Perf.
+0.90%
+2.39%
+1.21%
+9.46%
-10.72%
-0.43%
-0.43%
+0.97%
Flows

Key fund info

This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
ISIN
HK0001254553
AuM
€3.2M
TER
0.9%
Replication rating
Not rated
More details
NAV
7/2/2026
HK$14.35
1D NAV change
+4.39%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
N/A
Inception date
3/23/2026
Jurisdiction
Hong Kong
Distribution
Hong Kong
Legal structure
Open-end Fund
Base currency
HKD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The investment objective is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive Biopharma Select Index (the “Index”).
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Advertisement

Risk profile

Historical risk/return profile

3M1Y3Y5Y
Returns
-13.13%
N/A
N/A
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
Unavailable
100.00%
Sectors
Unavailable
100.00%
Diversification
This fund does not provide direct exposure to underlying securities.
Top 15 holdings
0
This fund does not provide direct exposure to underlying securities
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:
Not rated
1-year trailing difference
As of June 29, 2026
Create a free account to view the replication graph
03186
N/A
Replication quality
Calculated over 12m, as of June 29, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model

Issuer

E Fund Management
E Fund Management ID Card
Number of funds
22
Total AuM
€6.67B
Expense ratio range
0.08% - 1.4%
Average expense ratio
0.6332%

Frequently asked questions about 03186

What does E Fund (HK) Solactive Biopharma Select Index ETF, 03186, invest in?

03186 is a Passive ETF. This ETF provides exposure to Equally Weighted Biotechnology Equities.

Which benchmark or index does 03186 replicate?

03186 tracks the Solactive Biopharma Select Index - HKD, through a full replication replication method.

What is the Total Expense ratio (TER) of 03186?

03186 carries a total expense ratio (TER) of 0.9%, indicating the annual cost for holding the fund.

When was 03186 launched?

03186 was introduced to the market on March 23, 2026. It trades on Hong Kong

Who is the ETF issuer of 03186?

E Fund (HK) Solactive Biopharma Select Index ETF, 03186, is provided by E Fund Management. Learn more about E Fund Management here.

What is the current assets under management (AUM) of 03186?

03186 oversees €3.2M in assets as of July 2, 2026.

How has 03186 performed lately?

Based on data from July 2, 2026, 03186 returned 0.90% over the past month, 2.39% over the last three months and 0.97% year-to-date.

What are the latest inflows or outflows for 03186?

As of July 2, 2026, 03186 recorded net flows of -€42M over the last month and -€4M year-to-date.

Does 03186 distribute dividends?

03186 follows a distributing dividend policy, meaning it pays out income to investors.

What is the base currency of 03186?

The base currency of 03186 is HKD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight